Wire Stories

Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis

- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…

OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene Expression and Delivery of Candidate to Brain for CNS Therapeutics

SUWON, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…

Diamond Equity Research Releases Update Note on Medigus Limited (NASDAQ: MDGS)

NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research…

ARKO Reports First Quarter 2022 Results

Net Income Increases by $17.0 Million; Adjusted EBITDA Grows 18.4% in Q1 2022 Compared to…

Xperi and LAPIS, a ROHM Group Company, Enter into Hybrid Bonding License Agreement

Technology transfer includes DBI® Ultra die-to-wafer hybrid bonding know-how SAN JOSE, Calif. & YOKOHAMA, Japan--(BUSINESS…

Westwater Resources, Inc. Announces First Quarter Conference Call and Business Update

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite…

BeiGene Announces the Approval in China of BLINCYTO® (Blinatumomab) for Injection for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--$BGNE #BTKi--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235),…

China OTT and Pay TV Analysis and Forecasts for 2021, 2022 and 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China OTT and Pay TV Forecasts to 2027" report has been added to…

Key Trends and Opportunities in the Japanese Life Insurance Market to 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Life Insurance - Key Trends and Opportunities to 2025" report has been…

Singapore Wealth Management High Net Worth Investors Report 2022: The Average Singapore HNW Investor Offshores 42.3% of their Wealth Abroad – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Singapore Wealth Management - High Net Worth (HNW) Investors 2022" report has been…